Современные данные о биологии вируса герпеса человека 6 типа и патогенезе ассоциированных с ним клинических состояний (обзор научных публикаций)
https://doi.org/10.22625/2072-6732-2025-17-2-21-31
Аннотация
Несмотря на практически всеобщую инфицированность населения вирусом герпеса человека 6 типа во всем мире (до 90% людей считаются серопозитивными), герпес-ассоциированные заболевания остаются малоизученными. За последние 10 лет представления об этом микроорганизме значительно уточнились. В обзоре представлены современные данные о биологических свойствах вируса герпеса человека 6 типа, освещены эпидемиология, разнообразие клинических форм и вариантов течения инфекции, патогенез заболевания. Описаны специфические патогенетические особенности вируса герпеса человека 6 типа, определяющие трудности лабораторной диагностики инфекции и постановки диагноза и создающие проблемы при выборе тактики лечения.
Об авторах
П. А. Дроздовская
Национальный медицинский исследовательский центр им В.А. Алмазова;
Северо-Западный государственный медицинский университета им. И.И. Мечникова
Россия
Россия
Дроздовская Полина Андреевна – лаборант-исследователь отдела патоморфологии ЦДТИ ИЭМ; студентка
Санкт-Петербург
В. А. Цинзерлинг
Национальный медицинский исследовательский центр им В.А. Алмазова;
Северо-Западный государственный медицинский университета им. И.И. Мечникова;
Клиническая инфекционная больница им. С.П. Боткина
Россия
Россия
Цинзерлинг Всеволод Александрович – заведующий отделом патоморфологии ЦДТИ ИЭМ; профессор кафедры; руководитель центра инфекционной
патологии, д.м.н., профессор
Санкт-Петербург
Список литературы
1. Agut H, Bonnafous P, Gautheret-Dejean A. Human herpesviruses 6A, 6B, and 7. Microbiology Spectrum 2016; 4(3): DMIH2-0007-2015. doi: 10.1128/microbiolspec.DMIH2-0007-2015.
2. Caselli E, D’Accolti M, Caccuri F, et al. The U94 Gene of Human Herpesvirus 6: A Narrative Review of Its Role and Potential Functions. Cells. 2020; 9(12):2608. Published 2020 Dec 4. doi:10.3390/cells9122608.
3. Biberfeld P, Kramarsky B, Salahuddin SZ, Gallo RC. Ultrastructural characterization of a new human B lymphotropic DNA virus (human herpesvirus 6) isolated from patients with lymphoproliferative disease. Journal of the National Cancer Institute. 1987; 79(5):933-941.
4. Ablashi D, Agut H, Alvarez-Lafuente R, Clark DA, Dewhurst S, Diluca D, Flamand L, Frenkel N, Gallo R, Gompels UA, Hollsberg P, Jacobson S, Luppi M, Lusso P, Malnati M, Medveczky P, Mori Y, Pellett PE, Pritchett JC, Yamanishi K, Yoshikawa T. Classification of HHV-6A and HHV-6B as distinct viruses. Archives of Virology. 2014; 159:863–870. doi: 10.1007/s00705-013-1902-5.
5. Zou P, Isegawa Y, Nakano K, Haque M, Horiguchi Y, Yamanishi K. Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. Journal of Virology. 1999; 73(7):5926-5933. doi:10.1128/JVI.73.7.5926-5933.1999.
6. Agut H, Bonnafous P, Gautheret-Dejean A. Laboratory and clinical aspects of human herpesvirus 6 infections Clinical microbiology reviews. 2015;28(2):313-335. doi:10.1128/CMR.00122-14.
7. Gompels UA, Macaulay HA. Characterization of human telomeric repeat sequences from human herpesvirus 6 and relationship to replication. J Gen Virol. Journal of General Virology. 1995; 76 (Pt 2):451-458. doi:10.1099/0022-1317-76-2-451.
8. Cuende JI, Ruiz J, Civeira MP, et al. High prevalence of HHV-6 DNA in peripheral blood mononuclear cells of healthy individuals detected by nested-PCR. Journal of Medical Virology. 1994; 43:115–118. doi:10.1002/jmv.1890430203.
9. Okuno T, Takahashi K, Balachandra K, et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. Journal of clinical microbiology. 1989; 27:651–653. doi: 10.1128/jcm.27.4.651-653.1989.
10. Tesini BL, Epstein LG, Caserta MT. Clinical impact of primary infection with roseoloviruses. Current opinion in virology. 2014; 9:91-96. doi: 10.1016/j.coviro.2014.09.013.
11. Levy JA, Ferro F, Greenspan D, Lennette ET. Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet. 1990; 335(8697):1047-1050. doi:10.1016/0140-6736(90)92628-u.
12. Zerr DM, Meier AS, Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. The New England Journal of Medicine. 2005; 352(8):768-776. doi:10.1056/NEJMoa042207.
13. Никольский, М.А. Молекулярно-биологическая характеристика вируса герпеса человека 6-го типа у пациентов с различными вариантами течения заболевания / М.А. Никольский, А.А. Вязовая, В.Е. Ведерников [и др.] // Педиатрия. Журнал им. Г. Н. Сперанского. – 2019. – Т. 98, № 1. – С. 53–56.
14. Bates M, Monze M, Bima H, et al. Predominant human herpesvirus 6 variant A infant infections in an HIV-1 endemic region of Sub-Saharan Africa. Journal of Medical Virology. 2009; 81(5):779-789. doi:10.1002/jmv.21455
15. Maeda T, Okuno T, Hayashi K, et al. Outcomes of infants whose mothers are positive for human herpesvirus-6 DNA within the genital tract in early gestation. 1997. Acta Paediatrica. Japan. 39:653–657.
16. De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev. 2005; 18(1):217-245. doi:10.1128/CMR.18.1.217-245.2005.
17. Knowles WA, Gardner SD. High prevalence of antibody to human herpesvirus-6 and seroconversion associated with rash in two infants. Lancet. 1988; 2(8616):912-913. doi:10.1016/s0140-6736(88)92522-6.
18. Tarhan G, Yilmaz N, Ilhan F, Çeliker H, Cesur S, et al. Prevalence of Human Herpes Virus 6 (HHV-6) in Patients with Hemodialysis. Journal of infectious disease and therapy. 2015; 3:224. doi:10.4172/2332-0877.1000224.
19. Ishikawa K, Hasegawa K, Naritomi T, et al. Prevalence of herpesviridae and hepatitis virus sequences in the livers of patients with fulminant hepatitis of unknown etiology in Japan. Journal of Gastroenterology. 2002; 37:523-530.
20. Мелехина, Е.В. К вопросу о формировании бессимптомных форм инфекции, вызванной вирусом герпеса человека 6А/В, у детей / Е.В. Мелехина, О.О. Знойко, Д.Д. Абрамов [и др.] // Инфекционные болезни: Новости. Мнения. Обучение. – 2020. – Т. 9, № 1(32). – С. 78–87.
21. Nastke MD, Becerra A, Yin L, Dominguez-Amorocho O, Gibson L, Stern LJ, Calvo-Calle JM. Human CD4+ T cell response to human herpesvirus 6. Journal of Virology. 2012; 86:4776–4792.
22. Borghesi A, Cipelletti P, Maragliano R, Manzoni P, Stronati M. Human herpesvirus-6 associated neonatal urticaria multiforme. Arch Dis Child Fetal Neonatal Ed. 2013; 98(5): F450. doi:10.1136/archdischild-2012-301995.
23. Yamanishi K, Okuno T, Shiraki K, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet. 1988;1(8594):1065-1067. doi:10.1016/s0140-6736(88)91893-4.
24. Mullins TB, Krishnamurthy K. Roseola Infantum. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 4, 2023.
25. Kim F, Reichman V, Hooven TA. Human Herpesvirus-6 Meningitis in a Premature Infant with Fevers: A Case and Literature Review. Clinical Medicine Insights-Case Reports. 2020; 13:1179547620912952. doi:10.1177/1179547620912952
26. Baumer T, Fry C, Luppe S, Gunawardena H, Sieradzan K. Human herpes virus-6 encephalitis causing severe anterograde amnesia associated with rituximab, azathioprine and prednisolone combination therapy for dermatomyositis. Journal of NeuroVirology. 2017;23(3):508-510. doi:10.1007/s13365-017-0517-0
27. Knox KK, Harrington DP, Carrigan DR. Fulminant human herpesvirus six encephalitis in a human immunodeficiency virus-infected infant. J Med Virol. 1995; 45(3):288-292. doi:10.1002/jmv.1890450309.
28. Berzero G, Campanini G, Vegezzi E, et al. Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts. Neurol Neuroimmunol Neuroinflamm. 2021; 8(2):e942. doi:10.1212/NXI.0000000000000942.
29. Mendel I, Bertin C, Delaporte B, Maguer D, et al. Fulminant hepatitis in neonates with human herpesvirus 6 infection. Pediatr. Infect. Dis. J. 1995; 14:993-997.
30. Tajiri H., Tanaka-Taya K, Ozaki Y, et al. Chronic hepatitis in an infant, in association with human herpesvirus-6 infection. J. Pediatr. 1997;131:473-475.
31. De Rose DU, Auriti C, Lozzi S, et al. Severe herpes virus 6 interstitial pneumonia in an infant with three variants in genes predisposing to lung disease. J Med Virol. 2021; 93(8):5182-5187. doi:10.1002/jmv.27016
32. Balakrishna JP, Bhavsar T, Nicolae A, Raffeld M, Jaffe ES, Pittaluga S. Human Herpes Virus 6 (HHV-6)-associated Lymphadenitis: Pitfalls in Diagnosis in Benign and Malignant Settings. Am J Surg Pathol. 2018; 42(10):1402-1408. doi:10.1097/PAS.0000000000001121.
33. Portolani M, Cermelli C, Meacci M, et al. Primary infection by HHV-6 variant B associated with a fatal case of hemophagocytic syndrome. New Microbiol. 1997; 20(1):7-11.
34. Rahman AU, Baig F, Javid Chaudhary UI, Ashraf MB, et al. Hemophagocytic Lymphohistiocytosis Associated With Human Herpesvirus-6 (HHV-6) Infection in an Immunocompetent Adult: A Case Report. Cureus. 2024. 16(2), e54299. doi:10.7759/cureus.54299.
35. Rossi C, Delforge ML, Jacobs F, et al. Fatal primary infection due to human herpesvirus 6 variant A in a renal transplant recipient. Transplantation. 2001; 71(2):288-292. doi:10.1097/00007890-200101270-00021.
36. Luppi M, Barozzi P, Garber R, et al. Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases. Am J Pathol. 1998; 153(3):815-823. doi:10.1016/S0002-9440(10)65623-4.
37. Maeda A, Sata T, Enzan H, et al. The evidence of human herpesvirus 6 infection in the lymph nodes of Hodgkin’s disease. Virchows Arch A Pathol Anat Histopathol. 1993; 423(1):71-75. doi:10.1007/BF01606435.
38. Rojo J, Ferrer Argote VE, Klueppelberg U, et al. Semiquantitative in situ hybridization and immunohistology for antigen expression of human herpesvirus-6 in various lymphoproliferative diseases. In Vivo. 1994; 8(4):517-526.
39. Crawford JR, Santi MR. Thorarinsdottir HK, Cornelison R, et al. Detection of human herpesvirus-6 variants in pediatric brain tumors: Association of viral antigen in low grade gliomas. Journal of Clinical Virology. 46, 37-42. doi:10.1016/j.jcv.2009.05.011
40. Wells MJ, Jacobson S, Levine PH. An evaluation of HHV-6 as an etiologic agent in Hodgkin lymphoma and brain cancer using IARC criteria for oncogenicity. Infect Agent Cancer. 2019; 14:31. Published 2019 Nov 5. doi:10.1186/s13027-019-0248-3.
41. Yoshimoto, Goichi et al. Human Herpes Virus-6–Associated Encephalitis/Myelitis Mimicking Calcineurin Inhibitor–Induced Pain Syndrome in Allogeneic Stem Cell Transplantation Recipients. Biology of Blood and Marrow Transplantation. 2018. Volume 24, Issue 12, 2540 – 2548.
42. Feldstein AE, Razonable RR, Boyce TG, et al. Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients. Pediatr Transplant. 2003; 7(2):125-129. doi:10.1034/j.1399-3046.2003.00028.x.
43. Антонова, Т.В. Реактивация цитомегаловирусной инфекции, инфекций, вызванных вирусами герпеса человека 6 типа и Эпштейна – Барр, после трансплантации гемопоэтических стволовых клеток у детей / Т.В. Антонова, О.Е. Побегалова, О.В. Горчакова [и др.] // Журнал инфектологии. – 2023. – Т. 15, № 4. – С. 62–69. doi:10.22625/2072-6732-2023-15-4-62-69
44. Zerr DM, Ogata M. HHV-6A and HHV-6B in recipients of hematopoietic cell transplantation 2014., p 217–234. In Flamand L, Lautenschlager I, Krueger G, Ablashi D (ed), Human Herpesviruses HHV-6A, HHV-6B & HHV-7, 3rd ed. Elsevier, New York, NY. doi:10.1016/B978-0-444-62703-2.00013-6
45. Phan TL, Lautenschlager I, Razonable RR, Munoz FM. HHV-6 in liver transplantation: A literature review. Liver Int. 2018; 38(2):210-223. doi:10.1111/liv.13506.
46. Bartolini L, Theodore WH, Jacobson S, Gaillard WD. Infection with HHV-6 and its role in epilepsy. Epilepsy Res. 2019; 153:34-39. doi: 10.1016/j.eplepsyres.2019.03.016.
47. Komaroff AL, Pellett PE, Jacobson S. Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation. Clin Microbiol Rev. 2020; 34(1):e00143-20. Published 2020 Nov 11. doi:10.1128/CMR.00143-20.
48. Wang JQ, Yang HY, Shao X., Jiang XY, Li JM. Latent, Early or Late Human Herpes Virus-6B Expression in Adult Mesial Temporal Lobe Epilepsy: Association of Virus Life Cycle with Inflammatory Cytokines in Brain Tissue and Cerebral Spinal Fluid. Neuroscience. 2022; 504, 21–32. doi: 10.1016/j.neuroscience.2022.08.021.
49. Sokolovska L, Cistjakovs M, Matroze A, Murovska M, Sultanova A. From Viral Infection to Autoimmune Reaction: Exploring the Link between Human Herpesvirus 6 and Autoimmune Diseases. Microorganisms. 2024; 12(2):362. Published 2024 Feb 9. doi:10.3390/microorganisms12020362.
50. Caselli E, Zatelli MC, Rizzo R, et al. Virologichyr and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis. PLoS Pathog. 2012; 8(10):e1002951. doi: 10.1371/journal.ppat.1002951.
51. Seyyedi N, Dehbidi GR, Karimi M, et al. Human Herpesvirus 6A Active Infection in Patients with Autoimmune Hashimotos Thyroiditis. Braz. J. Infect. Dis. 2019, 23, 435–440.
52. Sultanova A, Cistjakovs M, Gravelsina S, et al. Association of active human herpesvirus-6 (HHV-6) infection with autoimmune thyroid gland diseases. Clin Microbiol Infect. 2017;23(1):50.e1-50.e5. doi: 10.1016/j.cmi.2016.09.023.
53. Skuja S, Svirskis S, Murovska M. Human Herpesvirus-6 and -7 in the Brain Microenvironment of Persons with Neurological Pathology and Healthy People. Int J Mol Sci. 2021; 22(5):2364. doi:10.3390/ijms22052364.
54. Donati D, Akhyani N, Fogdell-Hahn A, et al. Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology. 2003; 61(10):1405-1411. doi: 10.1212/01.wnl.0000094357.10782.f9.
55. Fox JD, Briggs M, Ward PA, Tedder RS. Human herpesvirus 6 in salivary glands. Lancet. 1990; 336(8715):590-593. doi: 10.1016/0140-6736(90)93392-3.
56. Robert C, Aubin JT, Visse B, Fillet AM, Huraux JM, Agut H. Difference in permissiveness of human fibroblast cells to variants A and B of human herpesvirus-6. Res Virol. 1996;147(4):219-225. doi: 10.1016/0923-2516(96)89652-x.
57. Grivel, JC, Santoro F, Chen S, Faga G, Malnati MS, et al. Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo. J. Virol. 2003. 77:8280-8289. doi: 10.1128/JVI.77.15.8280-8289.2003.
58. Rizzo R, Soffritti I, D’Accolti M, Bortolotti D, et al. HHV-6A/6B Infection of NK Cells Modulates the Expression of miRNAs and Transcription Factors Potentially Associated to Impaired NK Activity. Front. Microbiol. 2017, 8, 2143. doi:10.3389/fmicb.2017.02143.
59. Kondo K, Kondo T, Okuno T, Takahashi M, Yamanishi K. Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol. 1991; 72 (Pt 6):1401-1408. doi:10.1099/0022-1317-72-6-1401.
60. Caruso A, Caselli E, Fiorentini S, Rotola A, Prandini A, et al. U94 of human herpesvirus 6 inhibits in vitro angiogenesis and lymphangiogenesis. Proc. Natl. Acad. Sci. U.S.A. 2009. 106, 20446–20451. doi:10.1073/pnas.0905535106.
61. Zhen Z, Bradel-Tretheway B, Sumagin S, Bidlack JM, Dewhurst S. The human herpesvirus 6 G protein-coupled receptor homolog U51 positively regulates virus replication and enhances cell-cell fusion in vitro. Journal of Virology. 2005. 79: 11914-24. doi:10.1128/Jvi.79.18.11914-11924.2005.
62. Bronisz E, Kurkowska-Jastrzębska I. Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development. Mediators Inflamm. 2016; 2016:7369020. doi:10.1155/2016/7369020.
63. Kaufer BB, Flamand L. Chromosomally integrated HHV-6: impact on virus, cell and organismal biology. Curr Opin Virol. 2014; 9:111-118. doi:10.1016/j.coviro.2014.09.010.
64. Arbuckle JH, Medveczky MM, Luka J, et al. The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro. Proc Natl Acad Sci U S A. 2010;107(12):5563-5568. doi:10.1073/pnas.0913586107.
65. Gravel A, Hall CB, Flamand L. Sequence analysis of transplacentally acquired human herpesvirus 6 DNA is consistent with transmission of a chromosomally integrated reactivated virus. J Infect Dis. 2013; 207(10):1585-1589. doi: 10.1093/infdis/jit060.
66. Hall CB, Caserta MT, Schnabel K, et al. Chromosomal integration of human herpesvirus 6 is the major mode of congenital human herpesvirus 6 infection. Pediatrics. 2008; 122(3):513-520. doi:10.1542/peds.2007-2838.
67. Dantuluri KL, Konvinse KC, Crook J, Thomsen IP, Banerjee R: Human herpesvirus 6 detection during the evaluation of sepsis in infants using the FilmArray meningitis/encephalitis panel. J Pediatr. 2020, 223:204-206. doi: 10.1016/j.jpeds.2020.03.023.
68. Kharbat AF, Lakshmi-Narasimhan M, Bhaskaran S, Parat S. Incidental Detection of Human Herpesvirus-6 in Cerebrospinal Fluid Analysis: To Treat or Not to Treat?. Cureus. 2022; 14(6):e25629. Published 2022 Jun 3. doi:10.7759/cureus.25629.
69. Dagna L, Pritchett JC, Lusso P. Immunomodulation and immunosuppression by human herpesvirus 6A and 6B. Future Virol. 2013; 8(3):273-287. doi:10.2217/fvl.13.7.
70. Luppi M, Barozzi P, Morris C, et al. Human herpesvirus 6 latently infects early bone marrow progenitors in vivo. J Virol. 1999; 73(1):754-759. doi:10.1128/JVI.73.1.754-759.1999.
Рецензия
Для цитирования:
Дроздовская П.А., Цинзерлинг В.А. Современные данные о биологии вируса герпеса человека 6 типа и патогенезе ассоциированных с ним клинических состояний (обзор научных публикаций). Журнал инфектологии. 2025;17(2):21-31. https://doi.org/10.22625/2072-6732-2025-17-2-21-31
For citation:
Drozdovskaya P.A., Zinserling V.A. Modern data on the biology of Human Herpesvirus 6 and pathogenesis of Human Herpesvirus 6-associated clinical conditions (review of scientific publications). Journal Infectology. 2025;17(2):21-31. (In Russ.) https://doi.org/10.22625/2072-6732-2025-17-2-21-31
Просмотров:
124
.png)
.png)
Послать статью по эл. почте 